| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11. | Simris Group AB receives observation status | 88 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11. | Simris Group AB: Simris Group Interim Report January-september 2025 | 91 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11. | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 119 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11. | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 118 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10. | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 178 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09. | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 814 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08. | Simris Group AB: Simris Group Interim Report January-june 2025 | 166 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07. | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 152 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 28.05. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 283 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05. | Simris Group AB: Simris Group Interim Report January-march 2025 | 340 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02. | Simris Group AB: Simris Group Year-end Report January-december 2024 | 206 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen | |
| 04.02. | The observation status for Simris Group AB is removed | 316 | GlobeNewswire | On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 1,056 | +1,15 % | Im Schatten von Beyond Meat: Kurioser Handelstag: Erst Mega-Short-Squeeze, dann Pleitemeldung! | © Foto: picture alliance/Zoonar/Cigdem SimsekHinter den Anteilen von iRobot liegt ein kurioser Handelstag. Erst explodierte der Kurs, dann warnte das Unternehmen vor einer unmittelbar bevorstehenden... ► Artikel lesen | |
| OATLY GROUP | 10,600 | +1,92 % | Nach einer langen Durststrecke stellt Oatly wieder Gewinne in Aussicht und auch die Aktie schlägt sich wieder besser | Nur etwas mehr als vier Jahre liegt der Börsengang von Oatly zurück, der von viel Euphorie begleitet wurde. Der Aktienkurs schoss zeitweise auf mehr als 500 US-Dollar in die Höhe und nach oben schien... ► Artikel lesen | |
| CONAGRA BRANDS | 14,698 | +0,37 % | SCCM Enhanced Equity Income Fund Sold Conagra (CAG) in Q3 | ||
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 228,00 | +2,70 % | Wingstop to open first store in Thailand | ||
| WH GROUP | 0,905 | 0,00 % | Dividendenbekanntmachungen (06.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044096012 0,0397 USD 0,0338 EUR COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044098828 0... ► Artikel lesen | |
| ELSE NUTRITION | 0,106 | 0,00 % | Else Nutrition Holdings Inc.: Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025 | VANCOUVER, BC / ACCESS Newswire / December 4, 2025 / ELSE NUTRITION HOLDINGS INC. (TSX:BABY)(OTC PINK:BABYD) ("Else" or the "Company"), a global pioneer in whole-food, plant-based nutrition for babies... ► Artikel lesen | |
| MHP | 5,200 | +0,97 % | MHP has successfully closed the transaction to acquire over 92% stake in Grupo UVESA | KYIV, Ukraine, Aug. 4, 2025 /PRNewswire/ -- MHP, a leading international food and agri company, has officially closed the transaction to acquire over 92% of the share capital of Grupo UVESA... ► Artikel lesen | |
| BIOGAIA | 9,030 | +0,56 % | Neues Design, neue Produkte: BioGaia wird erwachsen | ||
| JACK IN THE BOX | 16,500 | +1,85 % | Here's What is Affected Jack in the Box's (JACK) Growth Plans | ||
| PP LONDON SUMATRA INDONESIA | 0,048 | 0,00 % | LSIP to distribute IDR 443.3 billion in dividends, yield exceeds 5%: After booking a near 100% surge in profit, ... | ||
| J&J SNACK FOODS | 77,00 | 0,00 % | Dividendenbekanntmachungen (16.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 2020 BULKERS LTD BMG9156K1018 0,2 USD 0,1699 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,395 EUR ALTAGAS LTD CA0213611001 0,315 CAD 0... ► Artikel lesen | |
| FIRST WATCH RESTAURANT GROUP | 17,700 | -2,16 % | First Watch Restaurant Group, Inc. Reports Q2 2025 Financial Results and Reaches 600th System-Wide Restaurant Milestone | Total revenues increased 19.1%Net income of $2.1 million and Adjusted EBITDA of $30.4 million17 new system-wide restaurants opened in 8 statesRaising 2025 Adjusted EBITDA guidance BRADENTON, Fla.... ► Artikel lesen | |
| CAVA GROUP | 53,34 | -2,11 % | Truist Securities initiates coverage on CAVA Group stock with Buy rating | ||
| PORTILLOS | 4,840 | -2,22 % | Portillo's Inc.: Portillo's Launches Season of Surprises Holiday Promotion Throughout December |